MAZE Maze Therapeutics posts narrower Q4 2025 loss than expected shares drop 237 percent amid missing quarterly revenue figures Is Cadiz CDZIP stock strengthening its trend Cadiz posts 89 negative EPS surprise on wider than projected loss Is Tilray Brands TLRY stock overvalued after recent rally 321 20260420 What Lionheart CUB disclosed about cost pressures CUB Q3 Earnings Lionheart Delivers Quarterly Results ByteDance May Invest Up to 89 Billion in AI Push to Strengthen Lead Over Chinese Rivals